Digital Therapeutics Market
Digital Therapeutics Market - Global Industry Assessment & Forecast
#
Pages:
156
Base Year:
2022
Feb - 2022
Format:
Report Code:
VMR-1327
Segments Covered
By
Application Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others
-
By
End-Use Patients, Providers, Payers, Employers, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 4.8 Billion |
 Revenue 2030:
|
USD 18.72 Billion |
 Revenue CAGR
(2023 - 2030): |
30.08% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Digital Therapeutics Market Segment Analysis
- Digital Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Digital Therapeutics End-Use Outlook (Revenue, USD Million, 2018 - 2030)
- Patients
- Providers
- Payers
- Employers
- Others
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
-
North America Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- U.S.
- U.S. Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- U.S. Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- U.S. Digital Therapeutics Market, by Application
- Canada
- Canada Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Canada Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Canada Digital Therapeutics Market, by Application
-
Mexico
- Mexico Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Mexico Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Mexico Digital Therapeutics Market, by Application
-
North America Digital Therapeutics Market, by Application
- Europe
-
Europe Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
-
Europe Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- U. K.
- U.K. Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- U.K. Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- U.K. Digital Therapeutics Market, by Application
- France
- France Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- France Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- France Digital Therapeutics Market, by Application
-
Germany
- Germany Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Germany Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Germany Digital Therapeutics Market, by Application
-
Italy
- Italy Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Italy Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Italy Digital Therapeutics Market, by Application
-
Spain
- Spain Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Spain Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Spain Digital Therapeutics Market, by Application
-
Rest of Europe
- Rest of Europe Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Rest of Europe Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Rest of Europe Digital Therapeutics Market, by Application
-
Europe Digital Therapeutics Market, by Application
- Asia Pacific
-
Asia Pacific Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
-
Asia Pacific Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- China
- China Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- China Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- China Digital Therapeutics Market, by Application
- Japan
- Japan Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Japan Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Japan Digital Therapeutics Market, by Application
-
Germany
- Germany Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Germany Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Germany Digital Therapeutics Market, by Application
-
India
- India Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- India Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- India Digital Therapeutics Market, by Application
-
South Korea
- South Korea Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- South Korea Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- South Korea Digital Therapeutics Market, by Application
-
South East Asia
- South East Asia Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- South East Asia Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- South East Asia Digital Therapeutics Market, by Application
-
Rest of Asia Pacific
- Rest of Asia Pacific Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Rest of Asia Pacific Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Rest of Asia Pacific Digital Therapeutics Market, by Application
-
Asia Pacific Digital Therapeutics Market, by Application
- Latin America
-
Latin America Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
-
Latin America Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Brazil
- Brazil Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Brazil Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Brazil Digital Therapeutics Market, by Application
- Argentina
- Argentina Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Argentina Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Argentina Digital Therapeutics Market, by Application
-
Rest of Latin America
- Rest of Latin America Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Rest of Latin America Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Rest of Latin America Digital Therapeutics Market, by Application
-
Latin America Digital Therapeutics Market, by Application
- Middle East & Africa
-
Middle East & Africa Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
-
Middle East & Africa Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- GCC Countries
- GCC Countries Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- GCC Countries Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- GCC Countries Digital Therapeutics Market, by Application
- South Africa
- South Africa Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- South Africa Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- South Africa Digital Therapeutics Market, by Application
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Digital Therapeutics Market, by Application
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
- Rest of Middle East & Africa Digital Therapeutics Market, by End-Use
- Patients
- Providers
- Payers
- Employers
- Others
- Rest of Middle East & Africa Digital Therapeutics Market, by Application
-
Middle East & Africa Digital Therapeutics Market, by Application
- North America
Vantage Market
Research | 24-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for Digital Therapeutics in terms of revenue?
-
The global Digital Therapeutics valued at USD 4.8 Billion in 2022 and is expected to reach USD 18.72 Billion in 2030 growing at a CAGR of 30.08%.
Which are the prominent players in the market?
-
The prominent players in the market are Omada Health Inc. (US), WellDoc Inc. (US), 2Morrow Inc (US)., Livongo Health (US), Propeller Health (US), Pear Therapeutics (US), Canary Health Inc. (US), Noom Health Inc. (US), Mango Health Inc. (US), Akili Interactive Labs (South Africa), Better Therapeutics (US), Happify Health (US), Kaia Health (US), Medtronic Plc. (Ireland), Teladoc Health Inc (US), and Fitbit Health Solutions (US)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 30.08% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Digital Therapeutics include
- Increased Adoption of EHR Solutions
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Digital Therapeutics in 2022.
